The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Venetoclax for the Treatment of Elderly Patients With CLL

Jacqueline C. Barrientos, MD
Published Online:9:48 PM, Wed December 6, 2017

Jacqueline C. Barrientos, MD, associate professor, The Feinstein Institute for Medical Research, Northwell Health, discusses venetoclax (Venclexta) for the treatment of elderly patients with chronic lymphocytic leukemia (CLL). 
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.